US and India reach trade deal, Astrazeneca shares move to NYSE
February 2, 2026 - 23:17
A significant trade agreement between the United States and India has captured market attention, signaling a potential deepening of economic ties between the two nations. While specific details of the pact were not immediately disclosed, the development is viewed as a positive step in resolving longstanding trade disputes and fostering increased cooperation.
In a separate major corporate move, pharmaceutical giant AstraZeneca has officially commenced trading on the New York Stock Exchange. The shift from the Nasdaq is seen as a strategic effort to enhance the company's visibility and attract a broader base of investors in the world's largest equity market. This transition marks a significant new chapter for the drugmaker.
Meanwhile, the retail sector is undergoing a leadership transition as two of America's largest chains, Target and Walmart, usher in new chief executives. These simultaneous changes at the top suggest a pivotal moment for the industry as companies navigate evolving consumer habits, inflationary pressures, and intense competition. The market is closely watching for the strategic directions these new leaders will implement.
MORE NEWS
March 20, 2026 - 05:04
ECB follows Bank of England with interest rate hold as Iran war intensifiesThe European Central Bank (ECB) has opted to leave its key interest rates unchanged, maintaining a pause in its historic tightening cycle. This decision mirrors the recent move by the Bank of...
March 19, 2026 - 04:53
Most Californians Expect Little Change to Their Finances Despite Economic UncertaintyA new survey reveals a striking contrast in the financial outlook of California residents. While an overwhelming majority believe the state`s economy is headed for difficult times and feel their...
March 18, 2026 - 04:39
Nvidia CEO Huang says company sees more than $1 trillion in sales through 2027Nvidia CEO Jensen Huang has provided further clarity on the company`s staggering financial outlook, solidifying expectations for sales to exceed $1 trillion through the year 2027. This projection...
March 17, 2026 - 18:14
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on SharesEli Lilly`s stock experienced a significant decline in Tuesday trading, dropping approximately 5% to around $937 per share. This downturn extends a challenging period for the pharmaceutical giant,...